Quoin Pharmaceuticals, Ltd. Quarterly Retained Earnings (Accumulated Deficit) in ILS for Q2 2021

Taxonomy & unit: us-gaap: ILS and USD
Description: The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary: Quoin Pharmaceuticals, Ltd. quarterly Retained Earnings (Accumulated Deficit) history and growth rate for Q2 2021.
Quoin Pharmaceuticals, Ltd. Retained Earnings (Accumulated Deficit) for the quarter ending June 30, 2021 was ₪129M.

Retained Earnings (Accumulated Deficit), Quarterly (ILS)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2021	129M			Jun 30, 2021	6-K	2021-08-24

* An asterisk sign (*) next to the value indicates that the value is likely invalid.